TY - JOUR
T1 - Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways
AU - Ricciardolo, Fabio L.M.
AU - Steinhoff, Martin
AU - Amadesi, Silvia
AU - Guerrini, Remo
AU - Tognetto, Michele
AU - Trevisani, Marcello
AU - Creminon, Christophe
AU - Bertrand, Claude
AU - Bunnett, Nigel W.
AU - Fabbri, Leonardo M.
AU - Salvadori, Severo
AU - Geppetti, Pierangelo
PY - 2000
Y1 - 2000
N2 - The protease activated receptor-2 (PAR-2) belongs to a family of G- protein-coupled receptors that are activated by proteolysis. Trypsin cleaves PAR-2, exposing an N-terminal tethered ligand (SLIGRL) that activates the receptor. Messenger RNA (mRNA) for PAR-2 was found in guinea pig airway tissue by reverse transcription-polymerase chain reaction, and PAR-2 was found by immunohistochemistry in airway epithelial and smooth muscle cells. In anesthetized guinea pigs, trypsin and SLIGRL-NH2 (given intratracheally or intravenously) caused a bronchoconstriction that was inhibited by the combination of tachykinin-NK1 and -NK2 receptor antagonists and was potentiated by inhibition of nitric oxide synthase (NOS). Trypsin and SLIGRL- NH2 relaxed isolated trachea and main bronchi, and contracted intrapulmonary bronchi. Relaxation of main bronchi was abolished or reversed to contraction by removal of epithelium, administration of indomethacin, and NOS inhibition PAR-1, PAR-3, and PAR-4 were not involved in the bronchomotor action of either trypsin or SLIGRL-NH2, because ligands of these receptors were inactive either in vitro or in vivo, and because thrombin (a PAR-1 and PAR-3 agonist) did not show cross-desensitization with PAR-2 agonists in vivo. Thus, we have localized PAR-2 to the guinea-pig airways, and have shown that activation of PAR-2 causes multiple motor effects in these airways, including in vivo bronchoconstriction, which is in part mediated by a neural mechanism.
AB - The protease activated receptor-2 (PAR-2) belongs to a family of G- protein-coupled receptors that are activated by proteolysis. Trypsin cleaves PAR-2, exposing an N-terminal tethered ligand (SLIGRL) that activates the receptor. Messenger RNA (mRNA) for PAR-2 was found in guinea pig airway tissue by reverse transcription-polymerase chain reaction, and PAR-2 was found by immunohistochemistry in airway epithelial and smooth muscle cells. In anesthetized guinea pigs, trypsin and SLIGRL-NH2 (given intratracheally or intravenously) caused a bronchoconstriction that was inhibited by the combination of tachykinin-NK1 and -NK2 receptor antagonists and was potentiated by inhibition of nitric oxide synthase (NOS). Trypsin and SLIGRL- NH2 relaxed isolated trachea and main bronchi, and contracted intrapulmonary bronchi. Relaxation of main bronchi was abolished or reversed to contraction by removal of epithelium, administration of indomethacin, and NOS inhibition PAR-1, PAR-3, and PAR-4 were not involved in the bronchomotor action of either trypsin or SLIGRL-NH2, because ligands of these receptors were inactive either in vitro or in vivo, and because thrombin (a PAR-1 and PAR-3 agonist) did not show cross-desensitization with PAR-2 agonists in vivo. Thus, we have localized PAR-2 to the guinea-pig airways, and have shown that activation of PAR-2 causes multiple motor effects in these airways, including in vivo bronchoconstriction, which is in part mediated by a neural mechanism.
UR - http://www.scopus.com/inward/record.url?scp=0034027359&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034027359&partnerID=8YFLogxK
U2 - 10.1164/ajrccm.161.5.9907133
DO - 10.1164/ajrccm.161.5.9907133
M3 - Article
C2 - 10806174
AN - SCOPUS:0034027359
SN - 1073-449X
VL - 161
SP - 1672
EP - 1680
JO - American Journal of Respiratory and Critical Care Medicine
JF - American Journal of Respiratory and Critical Care Medicine
IS - 5
ER -